TopoGEN has established Joint collaborative ventures with other biotechnology companies. These relationships create excellent synergy and promote new product ideas and business activity. TopoGEN uses a funding model to advance the goals of the joint venture. Specifcially, the company sponsors research based on validated and published science from other University faculty, other companies or collaborative partners. Please contact us (email@example.com) for further information.
Methylation (www.methylation.net) represents a joint venture of research diagnostics designed to provide products for developing an understanding of gene silencing in human disease. The company was founded in 2006 and has been profitable since 2008.
Funding Status: This company was started as a spin-off of TopoGEN using our funding model and starting with an SBIR grant.